Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,616 full-time employees. The firm offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
根據最新的財務報表(Form-10K),Orthofix Medical Inc 的總資產為 $850,淨損失為 $-92
OFIX 的關鍵財務比率是什麼?
Orthofix Medical Inc 的流動比率為 2.12,淨利潤率為 -11.19,每股銷售為 $20.75。
Orthofix Medical Inc 的收入按細分市場或地理位置如何劃分?
Orthofix Medical Inc 最大收入來源為 Spinal Implants, Biologics, and Enabling Technologies,在最近的收益報告中收入為 418,789,000。就地區而言,United States 是 Orthofix Medical Inc 的主要市場,收入為 620,829,000。